ScholarIQanswers from OpenAlex

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

PaperCitations, authors & open-access status

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial have?

ScholarIQcitation count

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial has 916 citations in the OpenAlex counts ScholarIQ stores.

When was The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial published?

ScholarIQyear

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial has 2022 year in the ScholarIQ index.

What is the open-access status of The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial?

ScholarIQoa status

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial has hybrid oa status in the ScholarIQ index.

What is the DOI of The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial?

ScholarIQdoi

The DOI for The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial is on the source record.

What is the PMID of The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial?

ScholarIQpmid

The PMID for The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial is on the source record.

What is the OpenAlex record for The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial?

ScholarIQopenalex

The OpenAlex for The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial